Eucomed launches five-year strategy to transform healthcare
17 October 2011
Eucomed, the European medical technology industry association,
has launched a 5-year industry strategy report ‘Contract for a Healthy
Future’ that outlines the role industry must play in steering healthcare
systems onto a sustainable path.
The medical technology industry acknowledges that it needs to
change and will embrace, deliver and demonstrate cost-efficiency and
health outcome needs of payers and policymakers, which is the
essence of value-based innovation.
The industry commits to playing its part and providing medical
technology innovations that ensure sustainable, accessible
healthcare and healthy ageing. Eucomed appeals to other healthcare
stakeholders to also reconsider their role as the industry cannot
achieve a healthy future for Europe on its own.
The Economist Intelligence Unit (EIU) opened the MedTech Forum
last week by launching its report ‘Future-proofing Western Europe’s
healthcare’. The report, sponsored by Eucomed, examines how selected
countries in Western Europe intend to future-proof their healthcare
systems as healthcare demand is growing while budgets are becoming
tighter. Five healthcare initiatives are highlighted that show
positive changes in preparing for the future.
The EIU report states that to meet the challenges of the future,
healthcare systems must be efficient, effective, integrated and
informed. The medical technology industry in Europe is ready to play
its role in increasing the productivity and efficiency of healthcare
systems as well as delivering crucial information by collecting,
developing and sharing evidence-based cases of technologies that
support healthy ageing.
“We have to rethink our healthcare systems in Europe and steer
them back onto a sustainable path. As an industry, innovation has
always been at the heart of what we do. But the future will demand a
different kind of innovative thinking from all stakeholders in our
economies. We will take the first step and deliver value-based
innovations that deliver a demonstrable positive return on
investment in healthy life years for citizens”, says Guy Lebeau,
Chairman of Eucomed.
The change needed in reforming European healthcare systems will
require other healthcare stakeholders to play their part too.
Industry will prove the cost-saving potential of medical technology
and deliver value-based innovation. In turn, it requests that
policymakers build better cost models and end silo-based budgeting,
while payers are requested to achieve health productivity and
efficiency by prioritising value not price.
John Wilkinson, Chief Executive of Eucomed adds: “The European
Commissioner for Health has stated on various occasions that we need
innovation in products, services, organisation, delivery and
financing. We believe it is short-sighted to cut back on medical
technologies when health budgets are squeezed, especially when you
consider that 70% of health spending is consumed by personnel and
hospital organisation. Compare that with medical technology which
accounts for less than 5%. If the industry delivers its promise and
enables healthcare systems to become more productive and efficient,
governments should reward us and invest in the right technologies”.
Eucomed launched a special website
www.reforminghealthcare.eu where more information on reforming
European healthcare systems can be found.